John C. King serves as Executive at Ra Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, John C. King has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 2, 2020 involved selling 10,823 shares valued at $519.5K.
John C. King currently holds 10,823 shares of Ra Pharmaceuticals, Inc. (RARX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John C. King has been a net neutral trader of RARX stock. They have purchased $0 and sold $0 worth of shares.
John C. King's most recent insider trade was on Apr 2, 2020, when they sold 10,823 shares at $48.00 per share.
Get notified when new Form 4 filings are submitted
| 4,506 |
| $21.93 |
| Discretionary |
| Apr 16, 2019 | RARX | $0 | Option Exercise | 15,329 | $N/A | Discretionary |